Keratinocyte transglutaminase enzymes serve to specifically catalyze the development of the cornified cell envelope, a defining characteristic of epidermal keratinocytes that have undergone the termination of differentiation.[7][8] The specific cross linkages formed by keratinocyte transglutaminase are between n^ε-(γ-glutamyl)lysine residues which develop into isopeptide protein-protein linkages that adds to the stabilization of the cornified cell envelope.[9]
In terminally differentiated stratified squamous epithelia, the cornified cell envelope protein linkages allow for a structurally fortified, yet flexible (15 nm thick) layer to the place of the cell membrane, acting as a highly insoluble barrier.[10] The expression of the enzyme is most highly exhibited along the biological membrane of these fully formed epithelial cells, preventing the cell from undergoing chemical and or physical damages. A lesser amount of enzymatic activity, of the TGK genes (5-10%), lies within the cytoplasmic fraction of such cells, allowing for finalization of the cross-linkaging necessary for the full functionality of the cornified cell envelope.
A study on the mutation of keratinocyte transglutaminase (TGK) came to conclude that those affected with ichthyosis lamellaris, present a substantial deficit in keratinocyte transglutaminase activity.[8] It was concluded that those afflicted, display a decrease in activity of the enzyme, as a result of a lessened amount of transcription of the human TGK gene. This lack of protein stems from a common mutation of the TGK gene, which exists in two possible variants, found at the TGM1 locus on the 14q11 chromosome, as exhibited amongst all the subjects of the study. Such mutations were of the compound heterozygous or homozygous variety, which leads to the expression of lamellar ichthyosis as a result of abnormal cross-linkaging of the cornified cell envelope.
Schroeder WT, Thacher SM, Stewart-Galetka S, Annarella M, Chema D, Siciliano MJ, et al. (July 1992). "Type I keratinocyte transglutaminase: expression in human skin and psoriasis". The Journal of Investigative Dermatology. 99 (1): 27–34. doi:10.1111/1523-1747.ep12611394. PMID1351505.
Yamanishi K, Liew FM, Konishi K, Yasuno H, Doi H, Hirano J, Fukushima S (March 1991). "Molecular cloning of human epidermal transglutaminase cDNA from keratinocytes in culture". Biochemical and Biophysical Research Communications. 175 (3): 906–13. doi:10.1016/0006-291X(91)91651-R. PMID1673840.
Polakowska R, Herting E, Goldsmith LA (February 1991). "Isolation of cDNA for human epidermal type I transglutaminase". The Journal of Investigative Dermatology. 96 (2): 285–8. doi:10.1111/1523-1747.ep12464554. PMID1704039.
Petit E, Huber M, Rochat A, Bodemer C, Teillac-Hamel D, Müh JP, et al. (1998). "Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity". European Journal of Human Genetics. 5 (4): 218–28. doi:10.1159/000484767. PMID9359043.
